Live Breaking News & Updates on Aurinia Lupkynis|Page 2
Stay updated with breaking news from Aurinia lupkynis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
3 Favorite Names With Exciting Potential I m looking for some trades as these names bounce around. Stocks quotes in this article: AUPH, POWW, ENGMF The market is trading mixed Monday, but I see some productive action in individual stocks I ve recently discussed. I m looking for some trades as these names bounce around. Aurinia Pharmaceuticals (AUPH) I discussed my short-term buy of AUPH on March 11. This morning news was released. There was a favorable assessment regarding the cost-effectiveness and value of Aurinia s Lupkynis by the Institute for Clinical and Economic Review in a revised Evidence Report issued on March 12. The report finds that Lupkynis represents an important new treatment option for patients living with lupus nephritis and at the estimated net price, determined the therapy to be priced in alignment with ICER s recommended health-benefit price benchmark ranges. ....
/PRNewswire/ The Lupus Foundation of America estimates that 1.5 million Americans, and at least five million people worldwide, have a form of lupus.[1] As. ....